Your browser doesn't support javascript.
loading
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
Tscherne, Alina; Schwarz, Jan Hendrik; Rohde, Cornelius; Kupke, Alexandra; Kalodimou, Georgia; Limpinsel, Leonard; Okba, Nisreen M A; Bosnjak, Berislav; Sandrock, Inga; Odak, Ivan; Halwe, Sandro; Sauerhering, Lucie; Brosinski, Katrin; Liangliang, Nan; Duell, Elke; Jany, Sylvia; Freudenstein, Astrid; Schmidt, Jörg; Werner, Anke; Gellhorn Serra, Michelle; Klüver, Michael; Guggemos, Wolfgang; Seilmaier, Michael; Wendtner, Clemens-Martin; Förster, Reinhold; Haagmans, Bart L; Becker, Stephan; Sutter, Gerd; Volz, Asisa.
Affiliation
  • Tscherne A; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Schwarz JH; Division of Virology, Department of Veterinary Sciences, German Center for Infection Research, 80539 Munich, Germany.
  • Rohde C; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Kupke A; Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
  • Kalodimou G; Institute of Virology, Marburg, German Center for Infection Research, 35392 Giessen-Marburg-Langen, Germany.
  • Limpinsel L; Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
  • Okba NMA; Institute of Virology, Marburg, German Center for Infection Research, 35392 Giessen-Marburg-Langen, Germany.
  • Bosnjak B; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Sandrock I; Division of Virology, Department of Veterinary Sciences, German Center for Infection Research, 80539 Munich, Germany.
  • Odak I; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Halwe S; Department of Viroscience, Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
  • Sauerhering L; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.
  • Brosinski K; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.
  • Liangliang N; Institute of Immunology, Hannover Medical School, 30625 Hannover, Germany.
  • Duell E; Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
  • Jany S; Institute of Virology, Marburg, German Center for Infection Research, 35392 Giessen-Marburg-Langen, Germany.
  • Freudenstein A; Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
  • Schmidt J; Institute of Virology, Marburg, German Center for Infection Research, 35392 Giessen-Marburg-Langen, Germany.
  • Werner A; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Gellhorn Serra M; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Klüver M; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Guggemos W; Division of Virology, Department of Veterinary Sciences, German Center for Infection Research, 80539 Munich, Germany.
  • Seilmaier M; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Wendtner CM; Division of Virology, Department of Veterinary Sciences, Ludwig-Maximilians-Universität München, 80539 Munich, Germany.
  • Förster R; Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
  • Haagmans BL; Institute of Virology, Marburg, German Center for Infection Research, 35392 Giessen-Marburg-Langen, Germany.
  • Becker S; Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
  • Sutter G; Institute of Virology, Marburg, German Center for Infection Research, 35392 Giessen-Marburg-Langen, Germany.
  • Volz A; Institute of Virology, Philipps University Marburg, 35037 Marburg, Germany.
Proc Natl Acad Sci U S A ; 118(28)2021 07 13.
Article in En | MEDLINE | ID: mdl-34162739

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / COVID-19 / Antibodies, Viral Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2021 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Neutralizing / Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / COVID-19 / Antibodies, Viral Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2021 Type: Article Affiliation country: Germany